Ian Bell
Senior VP & COOMr. Ian Bell is Senior Vice President & COO at Alcon Inc. He was the President of Global Business & Innovation at Alcon Inc. since September 2021 until September 01, 2024. Mr. Bell is Director at Aerie Pharmaceuticals, Inc. since November 21, 2022. He served as President of International at Alcon, Inc. overseeing the Europe, Russia, Middle East and Africa, Asia Pacific, Japan and Latin America and Caribbean markets since January 2019. He joined Alcon in March 2016 as President of Europe, Middle East and Africa (“EMEA”). Mr. Bell has experience in the medical device and pharmaceutical industries. Mr. Bell joined Alcon from for Hospira, Inc, where he served as Corporate Vice President and President of the EMEA region. Prior to his work at Hospira, Mr. Bell was Corporate Vice President and President of Allergan, Inc. Asia Pacific region, based in Singapore, from 2008 to 2014. Mr. Bell joined Allergan, Incorporatedin 2005 as Vice President and Managing Director of its neurosciences division for the EMEA region. Mr. Bell began his career at GlaxoSmithKline, where he held roles of increasing responsibility and scope in sales, marketing and strategy for more than 10 years. Mr. Bell was awarded the degree of Bachelor of Arts with honors in Economics from the University of York in the United Kingdom.
Positions
- Company NameAlcon Inc.Stock CodeALCPositionSenior VP & COOColleagues
- DJDavid J. EndicottCEO & Director
- FMF. Michael BallIndependent Chairman
- TCTimothy C. StonesiferSenior VP & CFO
- MBMargaret BuckleyChief Accounting Officer
- FLFranck LeveillerSVP of Global Research & Development and Chief Scientific Officer
- DKD. Keith GrossmanIndependent Vice Chair
- KJKaren J. MayIndependent Director
- RSRichard Scott Herrenindependent Director
